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Background: Patients who require transfusion as part of their clinical management have the right to expect sufficient
blood to be available to meet their needs and to receive the safest blood possible. Donor deferrals (disqualification)
lead to loss of precious blood donors and blood units available for transfusion purposes. It is believed that a large
majority of donor deferrals are due to temporal and correctable causes such as anemia in developing countries. It is
therefore important to determine anemia among donor population to inform decision-making on the type of
measures to be taken to reduce deferrals due to anemia. The aim of the study was to determine anemia in prospective
blood donors deferred by the copper sulphate technique of hemoglobin estimation. This, to provide information that
would help plan a future strategy for donor recruitment and management.
Methods: Three (3) ml of venous blood samples were collected from the study subjects into EDTA anticoagulant
tubes. The hemoglobin levels and red cell indices were measured using Sysmex hematology analyser. A thin blood
film was prepared and stained using Leishman stain and then observed under the light microscope.
Results: The prevalence of anemia among the total deferred patients (538) was 17.1 %. Four different types of anemia
were found among the subjects. These were normocytic normochromic (46.74 %), microcytic hypochromic (42.39 %)
normocytic hypochromic (8.70 %), and microcytic normochromic anemia (2.17 %).
Conclusion: The study showed that a significant number of the prospective blood donors deferred for having low
hemoglobin by the copper sulphate method turned out to have anemia by the standard method of diagnosis. Prevalence
of anemia among apparently healthy blood donors was therefore higher than expected. Measures must therefore be taken
to address this in order not to lose potential blood donors due to a correctable and preventable cause such as anemia.
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Blood transfusion is an essential part of health care. It
contributes to saving millions of lives each year in both
routine and emergency situations [1]. It permits increas-
ingly complex medical and surgical interventions and
dramatically increases the life expectancy and quality of
life of patients with a variety of acute and chronic condi-
tions [1, 2]. To make blood transfusion safe for patients,* Correspondence: s.antwi-baffour@chs.edu.gh
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transfusion community and the most important is the
selection of blood donors [2]. Blood donor suitability
standards are based on science, informed medical opinion,
and regulatory rules. These are criteria designed to protect
both the donor and the recipient [3]. Individuals disquali-
fied from donating blood are known as “deferred” donors
and they are deferred for various reasons [3].
Deferrals can be categorized as temporary short term
(1–56 days), temporary long term (57–365 days), and
multiple years/permanent (more than 365 days) [4]. The
key to recruiting and retaining safe blood donors is good
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which help to identify low-risk donor populations. Also, a
satisfying experience during blood donation, good donor
care and effective communication between blood dona-
tion centre staff and blood donors are all essential factors
for the retention of safe blood donors [1]. The deferral of
blood donors is a painful and sad experience for the blood
donor as well as the blood donation centre screening the
donor. These deferrals “bleed” the donor-recruiting efforts
of a blood centre, wasting efforts to gain new donors.
Moreover, deferring prospective donors often leaves them
with negative feelings about themselves as well as the
blood donation process [5]. Additionally these donors are
less likely to return for blood donation in the future [6].
In developing countries, it is believed that a large major-
ity of donor deferral could be due to a temporal and cor-
rectable cause such as anemia which is a condition of less
than normal levels of healthy red blood cells circulating in
the blood stream [7]. The severity of anemia is measured
by a person’s hemoglobin level and the causes could be
nutritional (e.g. iron) deficiency, haemorrhage, decreased
synthesis of red blood cells or hemoglobin, and so on
[8, 9]. Most donor centres use the copper sulphate
method to estimate blood levels and defer those who fail
the test. However, not all these people may be truly
anemic. It is therefore important to determine anemia
amongst them using the standard diagnostic method so
that those found to be truly anemic could be advised on
measures required to treat and prevent the anemia.
The truth is, estimates of anemia prevalence by them-
selves are only useful if they are associated with a picture
of the various causal factors that contribute to the devel-
opment of the anemia in specific settings [10, 11]. In-
deed these factors are multiple and complex and it is
critical to collect accurate information about them to
provide the basis for developing the best interventions
for anemia control [12, 13]. The overall objective of this
study was to determine anemia using standard diagnos-
tic methods in prospective blood donors deferred as a
result of failing to attain the expected blood levels re-
quired using the copper sulphate technique. The out-
come is expected to show who among those deferred
was truly anaemic and what type of anemia they have.
This will help in the planning of future strategies for
donor recruitment and management.
Methods
Study design
This study was a cross sectional study carried out in June 2012.
Study population
The subjects were consenting potential blood donors who
failed to meet the requirement for donation due to low
hemoglobin level using the copper sulphate technique.Ethical consideration
Ethical clearance for this research was sought from the
Ethics and Protocol Review Committee at the School
of Biomedical and Allied Health Sciences, University
of Ghana, Legon. All the participants gave their in-
formed consent before their samples were collected.
Materials
Some of the materials used include: Hematology analyser
(Sysmex 2000i), Sysmex cell pack and stromatolyser, 5ml
K2EDTA test tubes and Light Microscope.
Sample collection and analysis
Three millilitres (3 ml) of blood sample was collected
from each of the subject into Ethylene Diamine Tetra-
Acetic acid (EDTA) anticoagulant test tube. The samples
were then sent to the laboratory within 4 h of collection
to be analysed on the hematology analyzer (Sysmex
2000i). Thin blood film was prepared and stained using
Leishman stain for morphologic assessment of the red
blood cells. The film was then examined under the light
microscope using ×40 objective to select a good area for
examination and then a drop of oil placed on the film
and examined with the ×100 objective.
Data analysis
The statistical analysis of the data was done using the
Statistical Package for Social Sciences (SPSS) version
16.0. Data was represented as frequency Tables and
graphs. Pearson’s correlation was used to test the rela-
tionship between the various variables that was mea-
sured as well as the characteristics of the respondents.
Results
A total number of 1263 prospective blood donors
presented to donate blood during the period of this
study. Out of these, 1120 (88.68 %) were males and
143 (11.32 %) females. A total of 538 (42.6 %) involv-
ing 444 males and 94 females were deferred due to
varied reasons and 114 (21.2 %) of these were due to
low hemoglobin (Hb) level. These were assessed for
anemia using Hb and red cell indices from a
hematology autoanalyser and morphology. Those with
Hb < 13.5 for males and Hb < 12.0 for females were
termed as anemic. Ninety two (92) forming 80.7 % of
the 114 were eventually diagnosed with various forms
of anemia using the standard methods (FBC and
morphology). This represented 17.1 % of the total
number (538) deferred and 7.3 % of the total (1263)
prospective donors (Table 1). Twenty two (22) form-
ing 19.3 % of those who failed the copper sulphate
test were found not to be anemic.
The mean age of the 114 (68 males and 46 females)
deferred donors due to low blood levels was 30 years
Table 1 A Table of participant’s profiles, mean and standard deviation of the Hb concentrations and the frequencies of the severity
of anemias detected
PARAMETERS MALES FEMALES TOTAL
Number of donors 1120 (88.68 %) 143 (11.32 %) 1263
Number of deferrals 444 94 538
Number of deferrals due to low Hb by CuSO4 68 46 114
Minimum Hb (g/dl) 7.1 7.7
Maximum Hb (g/dl) 14.7 12.9
Mean Hb+/-SD 11.9/1.6 11.0/1.2
Mild anemia (Hb 10.0–13.5g/dl) 44 33 77
Moderate anemia (Hb 7.0–10.0g/dl) 9 6 15
From the Table, it shows that the number of male donors surpassed that of females by a wide margin, but among those deferred for low Hb, the numbers were
not that wide apart. The males also recorded both the lowest and highest Hb levels. It can also be seen that a greater number of participants had mild anemia in
comparison to moderate anemia
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Hb concentration and standard deviation of both males
and females was 11.5g/dl ±1.5 as well as Frequencies of
the severity of anemia in both sexes are all shown in
Table 1. The distribution of hemoglobin concentration is
shown in Fig. 1.
Four different types of anemia based on the red cell
indices and morphology studies were found in the par-
ticipants who were diagnosed with anemia. These were
normocytic normochromic, normocytic hypochromic,
microcytic normochromic and microcytic hypochromic.
Comparative analysis of gender and age distribution
against the types of anemia was also done and no correl-
ation was established (Table 2). Also analysed was the
distribution of the types of anemia in relation to the se-
verity. Majority of the respondents who had mild anemia
had normocytic normochromic anemia (51.95 %), while
the rest had microcytic hypochromic anemia (35.06 %),
normocytic hypochromic anemia (10.39 %) and micro-
cytic normochromic anemia (2.60 %). Majority of those
who had moderate anemia had microcytic hypochromic
anemia (80.00 %) and the rest had normocytic normo-





























Fig. 1 Diagram showing the distribution of hemoglobin concentrationsDiscussion
In spite of the many programs and interventions under-
taken by the various national blood transfusion services,
blood transfusion service centres continues to be unsuc-
cessful in their efforts to maintain required stock levels
of blood. A lot of potential donors are deferred for rea-
sons which are sometimes temporal (e.g. low Hb level)
and majority of these donors do not return to the centre
again. This study established that the deferral rate
among blood donors was significantly high (42.6 %) of
which low hemoglobin levels by CuSO4 formed 21.2 %.
This rate varies from the findings of a study in India
which had total deferral rate of 11.5 % of which 15.5 %
was due to anemia which incidentally compares well
with the 17.1 % obtained in our study [14, 15].
Our study discovered four types of anemia based on
the red cell indices and blood morphology. These were
normocytic normochromic, normocytic hypochromic,
microcytic normochromic and microcytic hypochro-
mic anemia. The types of anemia with the highest
frequency were normocytic normochromic anemia
(46.7 %) and microcytic hypochromic anemia (42.4 %).
The findings also showed that the prevalence of80 100 120
ECTS
HB
Table 2 Distribution of the types of anemia in relation to gender and age of participants









Sex Males 27 20 1 5 53
Females 16 19 1 3 39
Age cate-gory <20 5 1 1 1 8
21–25 8 11 1 3 23
26–30 13 10 0 2 25
31–35 8 8 0 1 17
36–40 3 7 0 1 11
41–45 4 1 0 0 5
46–50 1 0 0 0 1
51–55 1 0 0 0 1
56–60 0 1 0 0 1
It can be seen from the Table that a greater number of the participants presented with Normocytic normochromic, followed by Microcytic hypochromic,
Normocytic hypochromic and lastly Microcytic normochromic. Age category of 26–30 had the highest number of anemia cases
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males. Again, 83.7 % out of the 92 diagnosed with
anemia presented with mild anemia against 16.3 %
with moderate anemia [16]. This means that most of
them can have their blood levels improved in a short
period of time with proper advice and medication making
it possible to return at a later date to donate [17].
Furthermore, statistical analysis (Table 2) showed no
relationship between gender and type of anemia (p > 0.05),
neither was there a relationship between the age and type
of anemia (p > 0.05). Also, there was no relationship
between the ages of the respondents and the severity ofFig. 2 A graph of the distribution of the types of anemia in relation to the
anemia were categorised into mild anemia group with the Hb concentratio
7.0–10.0g/dl. From Fig. 2, it can be seen that majority of those with moder
presenting with normocytic normochromic type. On the other hand, those
normochromic groupanemia (p > 0.05) and between the gender of the respon-
dents and the severity of anemia (p > 0.05). The lack of
relationship between these parameters could be as a result
of the fact that the respondents were apparently healthy
individuals who had passed the same criteria for selection
for donation as healthy individuals prior to blood level
estimation. The results of the study however, showed
significant relationship between the severity of anemia
and the type of anemia (p < 0.05).
The findings from our study would help blood collec-
tion centres to plan a future strategy for donor recruit-
ment and management by using the standard method toseverity of the anemia. The participants who were diagnosed with
n of 10.0–13.5g/dl and moderate anemia with Hb concentration of
ate anemia had microcytic hypochromic anemia with the rest
with mild anemia had a fair distribution except for the microcytic
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procedure of Hb estimation. This way, people who
would be found truly anemic can be assisted to improve
their condition with informed advice and medication so
they can return to donate. Again, those found to be
falsely low can then go ahead and donate. In general, it
will help blood collection centres to develop and
implement strategies and tactics to manage blood
donors well and to evaluate the effectiveness of pro-
grams and services as far as donor safety is concern.
Subsequently they will be able to support the delivery,
sustainment and growth of donor recruitment and
retention [18, 19].
Furthermore, the outcome will also assist in formulat-
ing a policy guidance on providing blood donor counsel-
ling as an essential component of quality donor service
and care and as a requirement for a safe blood supply.
The counselling of blood donors is an important means
of promoting healthy lifestyles and makes an important
contribution to individual and community health [20].
In addition, counselling contributes to the early diagno-
sis and treatment of conditions such as anemia, blood
disorders and infections which will offer a crucial early
entry point for the treatment and care of donors found
to be unfit [21, 22]. Counselling may also reduce adverse
donor reactions, improve donor perceptions of the blood
transfusion services and, most importantly, increase the
likelihood of them returning for future donation [23].
This way, donor deferrals or lost particularly due to
anemia may be reduced.Conclusion
There was a high prevalence of deferral of prospective
blood donors and a significant proportion of these
deferred donors were as a result of low Hb levels and
subsequently anemia. Normocytic normochromic anemia
and microcytic hypochromic anemia were the most
common type of anemia detected. Most of them had
mild anemia which can be reversed in a short period of
time if the necessary advice and treatment is given. It
can therefore be concluded that people who fail the
copper sulphate procedure of Hb testing should not be
just sent way as deferred donors but rather be assessed
for anemia and be offered advice and treatment so that
if their anemia can be corrected, they are encouraged
to come back to donate.
Abbreviations
CuSO4: Copper sulphate; EDTA: Ethylene Diamine Tetra-Acetic acid; FBC: Full
Blood Count; Hb: Hemoglobin; RBC: Red Blood Cell; RDW: Red Cell
Distribution Width; WBC: White Blood Cell; WHO: World Health Organization.
Competing interests
We the authors of this manuscript declare that none of us as authors of this
paper has any conflict of interest in relation to this manuscript.Authors’ contributions
SAB participated in the design, co-supervised the research and drafted
the manuscript. DKA participated in the design of the study and carried
out the experimental work. JKA, RK, GK and FK participated equally in
the supervision of the work and proof reading of the manuscript. All
authors read and approved the final manuscript.Acknowledgements
We are grateful to Prof. Patrick F. Ayeh-Kumi the Dean of the School of
Biomedical and Allied Health Sciences (SBAHS), College of Health Sciences,
University of Ghana for his assistance in the development and drafting of
the manuscript. We will also like to acknowledge the following persons for
their help in putting the manuscript together: Dr. I.A Bello, Dr. Charles
Brown and Mr. David Nana Adjei, all of SBAHS.
Author details
1Department of Medical Laboratory Sciences, School of Biomedical and
Allied Health Sciences, College of Health Sciences, University of Ghana, P. O.
Box KB 143, Korle-Bu, Accra, Ghana. 2The Central Medical Laboratories,
Korle-bu Teaching Hospital, Accra, Ghana. 3College of Agriculture and Natural
Sciences, School of Biological Sciences, Department of Molecular Biology and
Biotechnology, University of Cape Coast, Cape Coast, Ghana.
Received: 23 May 2015 Accepted: 8 October 2015References
1. WHO 2010. Towards 100 % voluntary blood donation: a global framework
for action. Geneva: WHO press.
2. Sundar P, Sangeetha SK, Seema DM, Marimuthu P, Shivanna N. Pre-donation
deferral of blood donors in South Indian set-up: An analysis. Asian J
Transfus Sci. 2010;4(2):112–5.
3. Newman B. Blood donor suitability and allogeneic whole blood donation.
Transfus Med Rev. 2001;15(3):234–44.
4. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish
population. Transfus Med. 2007;17(5):379–83.
5. Brecher ME. AABB Technical Manual. 15th Edition. Bethedsa, MD: AABB
press; 2005. p. 101.
6. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of
temporary deferral on future whole blood donation. Transfusion.
2007;47(8):1514–23.
7. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide
prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information
System, 1993-2005. Public Health Nutr. 2009;12(4):444–54.
8. Urrechaga E, Hoffmann JJML, Escanero JF. From Wintrobe to the XXI
century. A Story of Inspiration and Effort, Int J Translation Community Dis.
2014;02(04):37–41.
9. Bach V, Schruckmayer G, Sam I, Kemmler G, Stauder R. Prevalence and
possible causes of anemia in the elderly: a cross-sectional analysis of a large
European university hospital cohort. Clin Interv Aging. 2014;9:1187–96.
10. Rahim F. Microcytic hypochromic anemia patients with thalassaemia:
Genotyping approach. Indian J Med Sci. 2009;63(3):101–8.
11. Green R. Anemias beyond B12 and iron deficiency: the buzz about other B’s,
elementary, and non elementary problems. ASH Education Book –. Hematology.
2012;2012(1):492–8.
12. Eivazi-Ziaei J, Dastgiri S, Pourebrahim S, Soltanpour R. Usefulness of red
blood cell flags in diagnosing and differentiating thalassemia trait from
iron-deficiency anemia. Hematology. 2008;13(4):253–6.
13. Rathod DA, Kaur A, Patel V, Patel K, Kabrawala R, Patel M, et al. Usefulness of
cell counter-based parameters and formulas in detection of beta-
thalassemia trait in areas of high prevalence. Am J Clin Pathol.
2007;128(4):585–9.
14. Bahadur S, Pujani M, Jain M. Donor deferral due to anemia: A tertiary care
center-based study. Asian J Transfus Sci. 2011;5(1):53–5.
15. Spivak JL. Anemia in the elderly: time for new blood in old vessels? Arch
Intern Med. 2005;165(19):2187–9.
16. Kariyeva GK, Magtymova A, Sharman A. Demographic and Health Surveys:
Chapter 12: Anemia. [Internet document available from http://
dhsprogram.com/pubs/pdf/fr130/12chapter12.pdf. accessed 2.9.2015].
Antwi-Baffour et al. BMC Hematology  (2015) 15:15 Page 6 of 617. World Health Organization. Iron deficiency anaemia: assessment, prevention,
and control: a guide for programme managers. Geneva, Switzerland: World
Health Organization; 2001.
18. Newman BH. Adjusting our management of female blood donors: the key
to an adequate blood supply. Transfusion. 2004;44:591–6.
19. Rabeya Y, Rapiaah M, Rosline H, Ahmed SA, Zaidah WA, Roshan TM. Blood
pre - donation deferrals - a tertiary hospital Experience. Southeast Asian J
Trop Med Public Health. 2008;39:571–4.
20. Davey RJ. The blood centre as a community health resource. Vox Sang.
2006;91(3):206–13.
21. Delaney MK et al. Blood center practice and education for blood donors
with anemia. Transfusion. 2011;51(5):929–36.
22. Allain JP et al. Deferred donor care in a regional hospital blood center in
Ghana. Transfusion. 2009;49(4):669–75.
23. Reiss RF. Blood donor well-being: a primary responsibility of blood
collection agencies. Ann Clin Lab Sci. 2011;41(1):3–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
